Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vanoxerine for recent onset atrial fibrillation/flutter
NCT01691313Phase 2Completed
- Sponsor
- ChanRx
- Start
- Nov 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vanoxerine in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by ChanRx. Started Nov 2012; status: completed.
02
Drugs
vanoxerine
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT01691313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691313.